Sort
17,054 grants matching “genome editing”
AAV capsid engineering for enhancing gene transfer
$697,416Mark A Kay · Stanford University · R01 · FY2022 · AI
Defining the Biology of the ADAR1-RISC Complex
$697,404Benjamin R. Tenoever · New York University School Of Medicine · R01 · FY2025 · AI
Defining the Biology of the ADAR1-RISC Complex
$697,404Benjamin R. Tenoever · New York University School Of Medicine · R01 · FY2022 · AI
Defining the Biology of the ADAR1-RISC Complex
$697,404Benjamin R. Tenoever · New York University School Of Medicine · R01 · FY2024 · AI
Defining the Biology of the ADAR1-RISC Complex
$697,404Benjamin R. Tenoever · New York University School Of Medicine · R01 · FY2023 · AI
Developing gene therapy strategies to treat alpha thalassemia
$697,241Tippi Mackenzie · University Of California, San Francisco · R01 · FY2025 · HL
Hepatic Gene Transfer for Treatment of Hemophilias A & B
$697,224Mark A Kay · Stanford University · R01 · FY2020 · HL
Hepatic Gene Transfer for Treatment of Hemophilias A & B
$697,224Mark A Kay · Stanford University · R01 · FY2021 · HL
Hepatic Gene Transfer for Treatment of Hemophilias A & B
$697,224Mark A Kay · Stanford University · R01 · FY2022 · HL
Hepatic Gene Transfer for Treatment of Hemophilias A & B
$697,224Mark A Kay · Stanford University · R01 · FY2019 · HL
Precision mapping of regulatory causal variants by expression CROPseq
$697,161Gregory C. Gibson · Georgia Institute Of Technology · R01 · FY2022 · HG
Applying a Human Liver Microphysiology System to Develop Therapeutic Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)
$696,977D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · DK
Streamlined development of an IND with the silica nanocapsule loaded with Cas9 genome editors to disrupt the dominant BEST1 mutant allele
$696,915Krishanu Saha · University Of Wisconsin-Madison · U19 · FY2023 · NS
Precision mapping of regulatory causal variants by expression CROPseq
$696,862Gregory C. Gibson · Georgia Institute Of Technology · R01 · FY2023 · HG
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy
$696,854Joseph C Wu · Stanford University · R01 · FY2022 · HL
AAV capsid engineering for enhancing gene transfer
$696,800Mark A Kay · Stanford University · R01 · FY2023 · AI
Functional interaction of transcriptional regulators in endocrine lineage specification
$696,480Doris A. Stoffers · University Of Pennsylvania · R01 · FY2025 · DK
Discovery of novel benzimidazole resistance mechanisms
$696,385Erik Christian Andersen · Northwestern University · R01 · FY2021 · AI
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing
$696,272Katharine June Bar · University Of Pennsylvania · R01 · FY2025 · MH
Human hypothalamic neuronal epigenomics and risk for obesity
$696,267Donna M Lehman · University Of Texas Hlth Science Center · R01 · FY2018 · DK
AAV capsid engineering for enhancing gene transfer
$696,224Mark A Kay · Stanford University · R01 · FY2024 · AI
Molecular mechanisms and genetic drivers of reciprocal genomic disorders
$696,041Michael E Talkowski · Massachusetts General Hospital · R01 · FY2020 · HD
Molecular mechanisms and genetic drivers of reciprocal genomic disorders
$696,041Michael E Talkowski · Massachusetts General Hospital · R01 · FY2019 · HD
Understanding Genetic Complexity in Spina Bifida
$695,911Margaret Elizabeth Ross · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · HD
Development of CRISPR/Cas9-based exon-skipping strategies for the treatment of USH-associated deafness
$695,726Xue Z Liu · University Of Miami School Of Medicine · R01 · FY2023 · DC